Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Am J Cardiol. 2013 Feb 1;111(3):333-8. doi: 10.1016/j.amjcard.2012.10.008. Epub 2012 Nov 17.
The high prevalence of unknown diabetes mellitus (DM) in patients with coronary disease and that the oral glucose tolerance test (OGTT) is the best diagnostic method in this context are well known. However, data about the incidence of DM in this population have not been well described. In the present study, we sought to determine the actual incidence of new-onset DM in patients with coronary disease using the OGTT. Our secondary objective was to validate a predictive model. We studied a series of 338 patients with coronary disease without known DM using the OGTT. After the OGTT, the patients were reclassified as normoglycemic, prediabetic, and unknown DM, according to the American Diabetes Association 2010 criteria. After 3 years of follow-up, the patients without DM were again reassessed using the OGTT. We then built a predictive model using the multivariate logistic regression method and validated it using the leave-one-out method. The final sample was 191 patients. The mean follow-up was 3.13 years. The overall incidence of DM was 43.6 cases/1,000 person-years (95% confidence interval [CI] 26.8 to 60.4). The incidence was significantly different between the initially normoglycemic patients (11.5%, 95% CI 2.3% to 31.8%) and the prediabetic patients (70.5%, 95% CI 42.7% to 98.3%; p <0.001). A risk model that included the glucose level 2 hours after challenge, glycosylated hemoglobin and triglyceride levels, and presence of noncoronary vascular disease showed good predictive capacity for incident DM (area under the curve 0.882, 95% CI 0.819 to 0.946; p <0.0001). In conclusion, the real incidence of new DM is very high in the coronary population, especially in those with prediabetes. It is necessary to use the OGTT for diagnosis, but we can optimize its indication using a risk model.
已知冠心病患者中存在较高比例的未知糖尿病(DM)患病率,且口服葡萄糖耐量试验(OGTT)是该情况下的最佳诊断方法。然而,有关该人群中 DM 发生率的数据尚未得到充分描述。在本研究中,我们旨在通过 OGTT 确定冠心病患者中新发 DM 的实际发生率。我们的次要目标是验证一个预测模型。我们使用 OGTT 研究了一组 338 例无已知 DM 的冠心病患者。OGTT 后,根据美国糖尿病协会 2010 标准,患者被重新分类为血糖正常、糖尿病前期和未知 DM。在 3 年的随访后,再次使用 OGTT 对无 DM 的患者进行评估。然后,我们使用多元逻辑回归方法构建预测模型,并使用留一法进行验证。最终样本为 191 例患者。平均随访时间为 3.13 年。DM 的总体发生率为 43.6 例/1000 人年(95%置信区间 [CI] 26.8 至 60.4)。最初血糖正常的患者(11.5%,95%CI 2.3%至 31.8%)和糖尿病前期患者(70.5%,95%CI 42.7%至 98.3%;p<0.001)之间的发生率存在显著差异。包括挑战后 2 小时血糖水平、糖化血红蛋白和甘油三酯水平以及非冠状动脉血管疾病存在的风险模型,对新发 DM 具有良好的预测能力(曲线下面积 0.882,95%CI 0.819 至 0.946;p<0.0001)。总之,在冠心病人群中,新 DM 的真实发病率非常高,尤其是在糖尿病前期患者中。OGTT 诊断是必要的,但我们可以使用风险模型来优化其适应证。